Innovation1 Biotech Inc. financial data

Industry
Pharmaceutical Preparations
Location
179 Rte 46 W, Suite 15 #147, Rockaway, NJ
State of incorporation
NV
Fiscal year end
August 31
Former names
GridIron BioNutrients, Inc. (to 3/10/2022), My Cloudz, Inc. (to 2/2/2018)
Latest financial report
10-Q - Q4 2023 - Jan 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.66 % +20.8%
Debt-to-equity -308 % -315%
Return On Equity 599 %
Return On Assets -288 % -270%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.5M shares 0%
Common Stock, Shares, Outstanding 22.5M shares +12.2%
Entity Public Float 6.24M USD 0%
Common Stock, Value, Issued 22.5K USD +12.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 0 USD -100%
General and Administrative Expense 194K USD -62%
Operating Income (Loss) -1.84M USD +56.8%
Nonoperating Income (Expense) 99.4K USD +3392%
Net Income (Loss) Attributable to Parent -5.61M USD +86.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.82K USD
Assets, Current 17.1K USD -85.9%
Property, Plant and Equipment, Net 1.31K USD -44.4%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 20.1K USD -99.5%
Accounts Payable, Current 357K USD +75%
Accrued Liabilities, Current 162K USD +64.1%
Liabilities, Current 2.66M USD +38.8%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 3.07M USD +42%
Retained Earnings (Accumulated Deficit) -59M USD -30.1%
Stockholders' Equity Attributable to Parent -3.05M USD -246%
Liabilities and Equity 20.1K USD -99.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 151K USD -22.7%
Net Cash Provided by (Used in) Financing Activities 107K USD +114%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22.5M shares +12.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.82K USD -48.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 133K USD +1002%
Deferred Tax Assets, Valuation Allowance 14.4M USD +19.6%
Deferred Tax Assets, Gross 10.8M USD +9.44%
Operating Lease, Liability 0 USD -100%
Depreciation 1.05K USD +33.4%
Operating Lease, Liability, Current 0 USD -100%
Additional Paid in Capital 56M USD +18%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 151K USD -3557%